Repair Research (BPC-157/TB-500)

Product Summary:

This research combo stack combines BPC-157 and TB-500, two peptides widely studied for their potential roles in tissue repair, wound healing, and anti-inflammatory effects. This stack provides an excellent option for researchers investigating synergistic effects on cellular regeneration and recovery mechanisms. Both compounds are offered in high-purity, research-grade formulations, ensuring reliability and reproducibility in experimental applications.

Key Features:

• High-Purity Peptides: Manufactured to meet strict quality standards for advanced research use.
• Synergistic Potential: Combines BPC-157 and TB-500 to investigate complementary actions on tissue repair and healing.
• Comprehensive Research Applications: Suitable for in vitro and in vivo studies focusing on recovery, inflammation, and regeneration mechanisms.

Product Details:

BPC-157:

• CAS Number: 137525-51-0
• Molecular Formula: C62H98N16O22
• Molecular Weight: 1419.53552 g/mol
• Appearance: White lyophilized powder
• Purity: ≥98% (HPLC)

TB-500 (Thymosin Beta-4 Fragment):

• CAS Number: 77591-33-4
• Molecular Formula: C212H350N56O78S
• Molecular Weight: 4963.49 g/mol
• Appearance: White lyophilized powder
• Purity: ≥98% (HPLC)

Packaging:

• Each kit includes:
  • 1 Vial of 5mg BPC157/5mg TB-500 combo
• Securely sealed under inert gas to maintain peptide integrity.

Applications:

• For Research Use Only: This combo is designed exclusively for research purposes, including:
  • Investigating cellular repair mechanisms.
  • Studying anti-inflammatory pathways.
  • Exploring angiogenesis and tissue regeneration.
• Not for human or veterinary consumption.

Potential Synergistic Mechanisms:

• BPC-157: Known for its potential to enhance tissue regeneration, angiogenesis, and protect cells from oxidative damage.
• TB-500: A fragment of Thymosin Beta-4, it is widely studied for its role in cell migration, anti-inflammatory effects, and repair of connective tissues.
• Together, these peptides are being explored for their complementary actions in promoting faster and more comprehensive recovery in preclinical studies.

Storage Instructions:

• Store at -20°C in a dry, tightly sealed container.
• Protect from light and moisture.
• Reconstituted peptides should be stored at 2–8°C and used within 7–14 days.

Regulatory and Patent Notice:

• Patent Disclaimer: BPC-157 and TB-500 may be subject to patents in some regions. Researchers are responsible for confirming compliance with applicable intellectual property laws.
• Compliance Warning: These compounds are not approved by the FDA or other regulatory agencies for clinical or therapeutic use. They are strictly for laboratory research.

Safety Information:

• Warnings:
  • Not intended for human or animal use.
  • For laboratory research only.
  • Misuse can result in legal and safety ramifications.
• Handling Precautions:
  • Use in a controlled laboratory environment by trained professionals.
  • Wear appropriate personal protective equipment (PPE).
  • Refer to the Safety Data Sheet (SDS) for handling guidelines.

Disclaimer:

This product is sold exclusively for lawful research applications. The buyer assumes all responsibility for regulatory compliance and the safe handling of these compounds.

Frequently Asked Questions (FAQ):

Q: What are the potential benefits of combining BPC-157 and TB-500?
A: Studies suggest that BPC-157 and TB-500 may have complementary mechanisms, including tissue repair, cell migration, and anti-inflammatory effects. However, these effects are only observed in controlled research settings.

Q: Can this combo stack be used in humans?
A: No. These peptides are strictly for research use and are not approved for therapeutic or diagnostic purposes.

Q: How should the peptides be reconstituted?
A: Both peptides can be reconstituted using sterile water or bacteriostatic water. Follow your laboratory’s protocols for proper dilution and storage.

Q: Are there interactions between BPC-157 and TB-500?
A: Researchers hypothesize potential synergy between these peptides, but additional studies are required to confirm specific interactions.

References:

• PubChem. (2024). BPC-157 and TB-500. Retrieved from pubchem.ncbi.nlm.nih.gov
• Clinical Peptide Society. (2024). Research Applications of Peptide Combinations. Retrieved from clinicalpeptidesociety.org
• MedChemExpress. (2024). TB-500 and BPC-157 Research Peptides. Retrieved from medchemexpress.com
• Wikipedia. (2024). BPC-157 and Thymosin Beta-4 Research. Retrieved from en.wikipedia.org